5th Annual Antibody Drug Conjugates (ADC) Summit: From Target to Therapeutics 2020

  • May 2020

Description

The 5th Annual Antibody Drug Conjugates (ADC) Summit: From Target to Therapeutics 2020 is dedicated to current challenges, best practices and the inside view of the future of Antibodies.

The 5th Annual Antibody Drug Conjugates (ADC) Summit: From Target to Therapeutics 2020 covers topics such as:

  • Emerging discoveries, cutting-edge knowledge, tools, methods, and technologies to bring clinically safe and efficient Antibodies
  • 360° view of Antibody from key industry players to leverage your business and scientific practice adoption
  • Novel approaches and Antibody formats to accelerate Antibody therapeutics

The 5th Annual Antibody Drug Conjugates (ADC) Summit: From Target to Therapeutics 2020 brings together attendees involved in:

  • Manufacturing/CMC
  • Antibody & Biologics Discovery /Development
  • Molecular Biology
  • Protein Engineering
  • Antibody-drug conjugates (ADCs)
  • Medicinal Chemistry
  • Immunoconjugates
  • Bioconjugates
  • Maytansine
  • Monoclonal antibodies (mAbs)
  • Duocarmycin
  • Tubulysins
  • α-amanitin
  • PBD-dimers
  • Marine-based cytotoxins
  • Topoisomerase inhibitors
  • Peptide-drug conjugates
  • Small-molecule drug conjugates
  • Diabodies/Minibodies
  • Nanoparticles/Nanobodies
  • ADME
  • PKPD
  • Analytical & Formulation
  • Toxicology
  • Cancer
  • Bioanalysis
  • Hematology
  • Oncology
  • Biotherapeutics
  • Antibody-based therapeutics
  • Chemotherapeutics
  • Immunotherapeutics

Past Events

Important

Please, check "Annual Antibody Drug Conjugates (ADC) Summit: From Target to Therapeutics" official website for possible changes, before making any traveling arrangements

Event Categories

Health & Medicine: Immunology, Pharma
Science: Biochemistry, Chemistry, Health sciences, Life Sciences & Biology
Technology: Biotechnology

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions